|
1
|
Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985.
|
Med J Aust
|
2006
|
2.27
|
|
2
|
Clinical whole-body skin examination reduces the incidence of thick melanomas.
|
Int J Cancer
|
2010
|
2.09
|
|
3
|
Clinical outcomes from skin screening clinics within a community-based melanoma screening program.
|
J Am Acad Dermatol
|
2005
|
1.56
|
|
4
|
Presentation and detection of invasive melanoma in a high-risk population.
|
J Am Acad Dermatol
|
2006
|
1.44
|
|
5
|
Prevalence of skin screening by general practitioners in regional Queensland.
|
Med J Aust
|
2004
|
1.40
|
|
6
|
Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
|
Lung Cancer
|
2005
|
1.29
|
|
7
|
Attitudes and intentions in relation to skin checks for early signs of skin cancer.
|
Prev Med
|
2004
|
1.06
|
|
8
|
Increase in skin cancer screening during a community-based randomized intervention trial.
|
Int J Cancer
|
2006
|
1.02
|
|
9
|
Overview of observational studies of low-dose helical computed tomography screening for lung cancer.
|
Respirology
|
2005
|
0.95
|
|
10
|
Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia.
|
Cancer
|
2009
|
0.94
|
|
11
|
A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009).
|
Cancer Epidemiol
|
2010
|
0.93
|
|
12
|
Prevalence of whole-body skin self-examination in a population at high risk for skin cancer (Australia).
|
Cancer Causes Control
|
2004
|
0.93
|
|
13
|
Comparability of skin screening histories obtained by telephone interviews and mailed questionnaires: a randomized crossover study.
|
Am J Epidemiol
|
2004
|
0.90
|
|
14
|
What motivates men age > or =50 years to participate in a screening program for melanoma?
|
Cancer
|
2006
|
0.88
|
|
15
|
Vitamin and mineral supplements in pregnancy and the risk of childhood acute lymphoblastic leukaemia: a case-control study.
|
BMC Public Health
|
2007
|
0.86
|
|
16
|
Association between melanoma thickness, clinical skin examination and socioeconomic status: results of a large population-based study.
|
Int J Cancer
|
2011
|
0.86
|
|
17
|
Do centralised skin screening clinics increase participation in melanoma screening (Australia)?
|
Cancer Causes Control
|
2006
|
0.80
|
|
18
|
Proteomic patterns in serum and identification of ovarian cancer.
|
Lancet
|
2002
|
0.79
|
|
19
|
Cancer control policy in Australia.
|
Aust New Zealand Health Policy
|
2006
|
0.78
|
|
20
|
Diagnosis and management costs of suspicious skin lesions from a population-based melanoma screening programme.
|
J Med Screen
|
2007
|
0.77
|
|
21
|
Prostate cancer, the PSA test and academic detailing in Australian general practice: an economic evaluation.
|
Aust N Z J Public Health
|
2005
|
0.77
|
|
22
|
Cancer education and training in primary health care--a national audit of training providers.
|
Aust Fam Physician
|
2007
|
0.77
|
|
23
|
A misleading paper on prostate cancer screening.
|
Prostate
|
2004
|
0.76
|
|
24
|
Missed melanomas - comment.
|
N Z Med J
|
2014
|
0.75
|
|
25
|
Increases in disease in Malayan war veterans' children may be misleading.
|
N Z Med J
|
2012
|
0.75
|
|
26
|
Study of effect of delays on ovarian cancer was weak.
|
BMJ
|
2002
|
0.75
|
|
27
|
Current international developments in population screening for colorectal cancer.
|
ANZ J Surg
|
2002
|
0.75
|
|
28
|
Cancer in Australia--an update for GPs.
|
Aust Fam Physician
|
2005
|
0.75
|
|
29
|
Critical factors influencing the establishment, maintenance and sustainability of population-based cancer control programs.
|
Tumori
|
2009
|
0.75
|
|
30
|
Opportunities to improve cancer care in Australia and New Zealand.
|
N Z Med J
|
2003
|
0.75
|
|
31
|
Who attends skin cancer clinics within a randomized melanoma screening program?
|
Cancer Detect Prev
|
2006
|
0.75
|
|
32
|
Helical computed tomography for lung cancer screening.
|
Med J Aust
|
2003
|
0.75
|